-
1
-
2
-
3Academic Journal
Authors: Yu. S. Korneva, R. V. Ukrainets, Ю. С. Корнева, Р. В. Украинец
Source: Surgery and Oncology; Том 9, № 2 (2019); 16-22 ; Хирургия и онкология; Том 9, № 2 (2019); 16-22 ; 2949-5857 ; 10.17650/2220-3478-2019-9-2
Subject Terms: GALT, mutsine, microsatellite instability, gut microbiota, proximal colon, муцины, микросателлитная нестабильность, кишечный микробиоценоз, проксимальный отдел толстой кишки
File Description: application/pdf
Relation: https://www.onco-surgery.info/jour/article/view/287/240; Melis M., Hernandez J., Siegel E.M. et al. Gene expression profiling of colorectal mucinous adenocarcinomas. Dis Colon Rectum. 2010;53(6):936—43. DOI:10.1007/DCR.0b013e3181d320c4.; Park J.S., Huh J.W., Park Y.A. et al. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer. Medicine (Baltimore) 2015;94(15):e658. DOI:10.1097/MD.0000000000000658; Pai R.K., Jayachandran P., Koong A.C. et al. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Am J Surg Pathol 2012;36(5):744—52. DOI:10.1097/PAS.0b013e31824430d.; Yoon Y.S., Kim J., Hong S.M. et al. Clinical implications of mucinous components correlated with microsatellite instability in patients with colorectal cancer. Colorectal Dis 2015;17(8):O161—7. DOI:10.1111/codi.13027.; Wang M.J., Ping J., Li Y. et al. Prognostic significance and molecular features of colorectal mucinous adenocarcinomas: a strobe-compliant study. Medicine (Baltimore) 2015;94(51):e2350. DOI:10.1097/MD.0000000000002350.; Maeda Y., Sadahiro S., Suzuki T. et al. Significance of the mucinous component in the histopathological classification of colon cancer. Surg Today 2016;46(3):303—8. DOI:10.1007/s00595-015-1150-2.; Verhulst J., Ferdinande L., Demetter P., Ceelen W. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol 2012;65(5):381 —8. DOI:10.1136/jclin-path-2011-200340.; Leopoldo S., Lorena B., Cinzia A. et al. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann Surg Oncol 2008;15(5):1429—39. DOI:10.1245/s10434-007-9757-1.; Papadopoulos V.N., Michalopoulos A., Netta S. et al. Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol 2004;8(suppl 1): s123—5.; Adell R., Marcote E., Segarra M.A. et al. Is mucinous colorectal adenocarcinoma a distinct entity? Gastroenterol Hepatol 2002;25(9):534—40.; Lin J.K., Shen M.Y., Lin T.C. et al. Distribution of a single nucleotide polymorphism of insulin-like growth factor-1 in colorectal cancer patients and its association with mucinous adenocarcinoma. Int J Biol Markers 2010;25(4):195—9.; Arfaoui Toumi A., Kriaa Ben Mahmoud L., Khiari M. et al. Epidemiological study, pathologic evaluation and prognostic factors of colorectal mucinous vs non-mucinous adenocarcinoma (a series of 196 patients). Tunis Med 2010;88(1):12—7.; Byrd J.C., Bresalier R.S. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004;23(1—2): 77-99.; Ionila M., Margaritescu C., Pirici D., Mogoanta S.S. Mucinous adenocarcinoma of the colon — a histochemical study. Rom J Morphol Embryol 2011;52(3): 783—90.; Park E.T., Oh H.K., Gum J.R.Jr. et al. HATH1 expression in mucinous cancers of the colorectum and related lesions. Clin Cancer Res 2006;12(18):5403—10.; Du W., Mah J.T., Lee J. et al. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum 2004;47(1):78—85.; Buisine M.P., Devisme L., Savidge T.C. et al. Mucin gene expression in human embryonic and fetal intestine. Gut 1998;43(4):519—24.; Reid C.J., Harris A. Developmental expression of mucin genes in the human gastrointestinal system. Gut 1998;42(2):220 —6.; Kazama Y., Watanabe T., Kanazawa T. et al. Mucinous carcinomas of the colon and rectum show higher rates of microsatellite instability and lower rates of chromosomal instability: a study matched for T classification and tumor location. Cancer 2005;103(10):2023—9.; Kakar S., Aksoy S., Burgart L.J., Smyrk T.C. Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Mod Pathol 2004;17(6):696—700.; Barresi V., Reggiani Bonetti L., Ieni A. et al. Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinous adenocarcinoma. Hum Pathol 2015;46(11):1722—9. DOI:10.1016/j.humpath.2015.07.013.; Lee M.S., Menter D.G., Kopetz S. Right versus left colon cancer biology: integrating the consensus molecular subtypes. J Natl Compr Canc Netw 2017;15(3):411—9.; Perez-Villamil B., Romera-Lopez A., Hernandez-Prieto S. et al. Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior. BMC Cancer 2012;12:260. DOI:10.1186/1471-2407-12-260.; Eyking A., Reis H., Frank M. et al. MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer. PLoS One 2016;11(6):e0156871. DOI:10.1371/jour-nal.pone.0156871.; Kim K., Castro E.J.T., Shim H. et al. Differences Regarding the Molecular Features and Gut Microbiota Between Right and Left Colon Cancer. Ann Coloproctol 2018;34(6):280—5. DOI:10.3393/ac.2018.12.17.; Волкова О.В., Пекарский М.И. Эмбриогенез и возрастная гистология внутренних органов человека. М.: Медицина, 1976. 414 с.; Морозова Е.Н., Морозов В.Н., Кузьмачук Д.О., Моргун Ю.А. Взгляд на морфогенез пейеровых бляшек тонкой кишки крыс. Вестник проблем биологии и медицины 2013;2(2):101.; Карпочева И.Г., Галеева Э.Н. Анатомофункциональная характеристика лимфоидной системы и ее становление в пренатальном онтогенезе. Современные проблемы науки и образования 2017;2:86.; Peaudecerf L., Rocha B. Role of the gut as a primary lymphoid organ. Immunol Lett 2011;140(1-2):1—6. DOI:10.1016/j.im-let.2011.05.009.; Gordon J.I., Hooper L.V., McNevin M.S. et al. Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: conversations between the microflora, epithelium, and diffuse GALT. Am J Physiol 1997;273(3 Pt 1):G565—70.; Neumann P.A., Koch S., Hilgarth R.S. et al. Gut commensal bacteria and regional Wnt gene expression in the proximal versus distal colon. Am J Pathol 2014;184(3):592—9. DOI:10.1016/j.ajpath.2013.11.029.; Гусейнов Т.С., Гусейнова С.Т. Дискуссионные вопросы анатомии пейеровых бляшек тонкой кишки. Саратовский научно-медицинский журнал 2012;8(3):687—91.; Merlano M.C., Granetto C., Fea E. et al. Heterogeneity of colon cancer: from bench to bedside. ESMO Open 2017;2(3):e000218. DOI:10.1136/esmoo-pen-2017-000218.; Kashtanova D.A., Popenko A.S., Tkacheva O.N. et al. Association between the gut microbiota and diet: Fetal life, early childhood, and further life. Nutrition 2016;32(6): 620-7. DOI:10.1016/j.nut.2015.12.037.; Kosumi K., Hamada T., Koh H. et al. The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome. Am J Pathol 2018;188(12): 2839-52. DOI:10.1016/j.aj-path.2018.08.015.; Wu M., Wu Y., Li J. et al. The dynamic changes of gut microbiota in Muc2 deficient mice. Int J Mol Sci 2018;19(9). PII: E2809. DOI:10.3390/ijms19092809.; Kamphuis J.B.J., Mercier-Bonin M., Eutamene H., Theodorou V. Mucus organisation is shaped by colonic content; a new view. Sci Rep 2017;7(1):8527. DOI:10.1038/s41598-017-08938-3.; Koliarakis I., Psaroulaki A., Nikolouzakis T.K. et al. Intestinal microbiota and colorectal cancer: a new aspect of research. CJ BUON 2018;23(5):1216—34.; Hattori N., Niwa T., Ishida T. et al. Antibiotics suppress colon tumorigenesis through inhibition of aberrant DNA methylation in an azoxymethane and dextran sulfate sodium colitis model. Cancer Sci 2019;110(1): 147—56. DOI:10.1111/cas.13880.; Mima K., Nishihara R., Qian Z.R. et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 2016;65(12):1973—80. DOI:10.1136/gutjnl-2015-310101.; Mima K., Sukawa Y., Nishihara R. et al. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol 2015;1(5):653—61. DOI:10.1001/jamaon-col.2015.1377.; Gao Z., Guo B., Gao R. et al. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol 2015;6:20. DOI:10.3389/fmicb.2015.00020.; Flemer B., Lynch D.B., Brown J.M. et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 2017;66(4):633—43. DOI:10.1136/gutjnl-2015-309595.
-
4Academic Journal
Authors: M. Ju. Stepanyan, E. V. Komarova, М. Ю. Степанян, Е. В. Комарова
Contributors: АЛВИЛС Патент, ООО
Source: Pediatric pharmacology; Том 13, № 6 (2016); 592-596 ; Педиатрическая фармакология; Том 13, № 6 (2016); 592-596 ; 2500-3089 ; 1727-5776
Subject Terms: пребиотики, intestine, intestinal microbiocenosis, dysbiosis, probiotics, prebiotics, кишечник, кишечный микробиоценоз, дисбиоз, пробиотики
File Description: application/pdf
Relation: https://www.pedpharma.ru/jour/article/view/1485/873; Уголев А.М. Эволюция пищеварения и принципы эволюции функций. — Л.: Наука; 1985. — 544 с. [Ugolev AM. Evolyutsiya pishchevareniya i printsipy evolyutsii funktsii. Leningrad: Nauka; 1985. 544 p. (In Russ).]; Дисбактериоз кишечника, как клинико-лабораторный синдром: современное состояние проблемы. Руководство для врачей / Под ред. Бондаренко В.М., Мацулевич Т.В. — М.; 2007. — 300 с. [Disbakterioz kishechnika, kak kliniko-laboratornyi sindrom: sovremennoe sostoyanie problemy. Rukovodstvo dlya vrachei. Ed by Bondarenko V.M., Matsulevich T.V. Moscow; 2007. 300 p. (In Russ).]; Дисбактериоз и дисбиоз кишечника / Под ред. Барановского А.Ю., Кондрашиной Э.А. 2-е изд. — СПб.: Питер; 2002. — 209 с. [Disbakterioz i disbioz kishechnika. Ed by Baranovskii A.Yu., Kondrashina E.A. 2nd ed. St. Petersburg: Piter; 2002. 209 p. (In Russ).]; Шендеров Б.А. Медицинская микробная экология и функциональное питание. — М.: ГрантЪ; 2001. — 287 с. [Shenderov BA. Meditsinskaya mikrobnaya ekologiya i funktsional’noe pitanie. Moscow: Grant””; 2001. 287 p. (In Russ).]; Макарова С.Г., Намазова-Баранова Л.С. Кишечная микробиота и применение пробиотиков в практике педиатра. Что нового? // Педиатрическая фармакология. — 2015. — Т. 12. — № 1 — С. 38–45. [Makarova SG, Namazova-Baranova LS. Intestinal microbiota and use of probiotics in pediatric practice: news. Pediatric pharmacology. 2015;12(1): 38–45. (In Russ).] doi:10.15690/pf.v12i1.1245.; Human Microbiome Project Consortium. A framework for human microbiome research. Nature. 2012;486(7402):215–221. doi:10.1038/nature11209.; The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214. doi:10.1038/nature11234.; Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488(7410):178–184. doi:10.1038/nature11319.; Jeffery IB, Claesson MJ, O’Toole PW, Shanahan F. Categorization of the gut microbiota: enterotypes or gradients? Nat Rev Microbiol. 2012;10(9):591–592. doi:10.1038/nrmicro2859.; Kau AL, Ahern PP, Griffin NW, et al. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474(7351): 327–336. doi:10.1038/nature10213.; Goodacre R. Metabolomics of a superorganism. J Nutr. 2007; 137(1 Suppl):259S–266S.; Биологические законы и жизнеспособность человека: метод многофункциональной восстановительной биотерапии / Под ред. Черешнева В.А., Морова А.А., Рямзина И.Н. 2-е изд., перераб. и доп. — Пермь: Звезда; 2000. — 166 с. [Biologicheskie zakony i zhiznesposobnost’ cheloveka: metod mnogofunktsional’noi vosstanovitel’noi bioterapii. Ed by Chereshnev V.A., Morov A.A., Ryamzin I.N. 2nd ed. Perm: Zvezda; 2000. 166 p. (In Russ).]; Циммерман Я.С. Дисбиоз (дисбактериоз) кишечника и (или) «синдром избыточного бактериального роста» // Клиническая медицина. — 2005. — Т. 83. — № 4 — С. 14–22. [Tsimmerman YaS. Intestinal dysbiosis (dysbacteriosis) 14 and/or «excessive bacterial growth syndrome». Klin Med (Mosk). 2005;83(4):14–22. (In Russ).]; Унич Н.К. Дисбактериоз кишечника у детей // Medicus Amicus. — 2002 — № 3. [Unich NK. Disbakterioz kishechnika u detei. Medicus Amicus. 2002;(3). (In Russ).] Доступно по: http:// www.medicusamicus.com/index.php?action=2x72-5-7a-12-13-14-8-28-29-37-38x3. Ссылка активна на 12.12.2016.; Nissle A. Uber die Grundlagen einer neuen ursachlichen Bekampfung der pathologischen Darmflora. Dtsch Med Wochenschr. 1916;42(39):1181–1184. doi:10.1055/s-0028-1135392.; Шептулин А.А. Синдром избыточного роста бактерий и «дисбактериоз кишечника»: их место в современной гастроэнтерологии // Российский журнал гастроэнтерологии, гепатологии и колопроктологии. — 1999. — Т. 8. — № 3 — С. 51–53. [Sheptulin AA. Sindrom izbytochnogo rosta bakterii i «disbakterioz kishechnika»: ikh mesto v sovremennoi gastroenterologii. Russian journal of gastroenterology, hepatology, coloproctology. 1999;8(3):51–53. (In Russ).]; Минушкин О.Н. Дисбактериоз кишечника: современное состояние проблемы // Consilium medicum. — 2007. — Т. 9. — № 7. — С. 59–64. [Minushkin ON. Disbakterioz kishechnika: sovremennoe sostoyanie problemy. Consilium medicum. 2007; 9(7):59–64. (In Russ).]; Белоусова Е.А. Дисбактериоз кишечника. В кн.: Руководство по гастроэнтерологии / Под ред. Комарова Ф.И., Рапопорт С.И. — М.; 2010. — С. 310–341. [Belousova EA. Disbakterioz kishechnika. In: Komarova FI, Rapoport SI. Rukovodstvo po gastroenterologii. Moscow; 2010. p. 310–341. (In Russ).]; Макарова С.Г. Пребиотики как функциональный компонент питания ребенка // Вопросы современной педиатрии. — 2013. — Т. 12. — № 5 — С. 8–17. [Makarova SG. Prebiotics as a «functional» component of child nutrition. Current pediatrics. 2013;12(5): 8–17. (In Russ).] doi:10.15690/vsp.v12i5.792.; Парфенов А.И. Кишечный дисбактериоз // Лечащий врач. — 2001. — № 5–6. [Parfenov AI. Kishechnyi disbakterioz. Lechashchii vrach. 2001;(5–6). (In Russ).] Доступно по: http://www.lvrach.ru/2001/05-06/4528776/. Ссылка активна на 12.12.2016.; Рябчук Ф.Н. Современные жидкие симбиотики и синбиотики в коррекции микробиоценоза при острых и хронических заболеваниях органов пищеварения. Учебное пособие для врачей. — СПб.; 2013. — 25 с. [Ryabchuk FN. Sovremennye zhidkie simbiotiki i sinbiotiki v korrektsii mikrobiotsenoza pri ostrykh i khronicheskikh zabolevaniyakh organov pishchevareniya. Uchebnoe posobie dlya vrachei. St. Petersburg; 2013. 25 p. (In Russ).]; FAO/WHO. Report on Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina; 2001. 34 p.; Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol. 2000;95(1 Suppl):2–4. doi:10.1016/s0002-9270(99)00806-0.; Collins JK, Thornton G, Sullivan GO. Selection of probiotic strains for human application. Int Dairy J. 1998;8(5–6):487–490. doi:10.1016/s0958-6946(98)00073-9.; Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek. 2002;82(1–4): 279–289. doi:10.1023/A:1020620607611.; Gorbach SL. Probiotics in the third millennium. Dig Liver Dis. 2002:34 Suppl 21:S2–7. doi:10.1016/s1590-8658(02)80155-4.; Шевяков М.А. Коррекция дисбиоза кишечника: современные подходы // Лечащий врач. — 2007. — № 6. [Shevyakov MA. Korrektsiya disbioza kishechnika: sovremennye podkhody. Lechashchii vrach. 2007;(6). (In Russ).] Доступно по: http://www. lvrach.ru/2007/06/4535355/. Ссылка активна на 12.1.2.2016.; Gibson GR, Probert HM, Loo JV, et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 2004;17(2):259–275. doi:10.1079/NRR200479.; Roberfroid MB. Concepts in functional foods: the case of inulin and oligofructose. J Nutr. 1999;129(7 Suppl):1398S–1401S.; Лоранская И.Д., Лаврентьева О.А. Функциональный анализ микробиоценоза желудочно-кишечного тракта // Русский медицинский журнал. — 2011. — Т. 19. — № 17 — С. 1057–1060. [Loranskaya ID, Lavrent’eva OA. Funktsional’nyi analiz mikrobiotsenoza zheludochno-kishechnogo trakta. Russkii meditsinskii zhurnal. 2011;19(17):1057–1060. (In Russ).]; Chilton SN, Burton JP, Reid G. Inclusion of fermented foods in food guides around the world. Nutrients. 2015;7(1):390–404. doi:10.3390/nu7010390.; Хавкин А.И. Микрофлора пищеварительного тракта. — М.: Фонд социальной педиатрии; 2006. — 416 с. [Khavkin AI. Mikroflora pishchevaritel’nogo trakta. Moscow: Fond sotsial’noi pediatrii; 2006. 416 p. (In Russ).]; https://www.pedpharma.ru/jour/article/view/1485
-
5Academic Journal
File Description: text/html
-
6Report
Authors: Yu M Markova, A A Shumakova, A V Selifanov, V A Shipelin, S A Khotimchenko, T V Pichugina, A S Polyanina, E N Trushina, I V Gmoshinsky, Kh. S. Soto, O K Mustafina
Source: Voprosy pitaniia. 86(4)
-
7Academic Journal
-
8Academic Journal
Authors: Иванова, Елена, Попкова, София, Джиоев, Юрий, Долгих, Владимир, Ракова, Елена, Бухарова, Екатерина
Subject Terms: КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ, ФУНКЦИОНАЛЬНЫЕ НАРУШЕНИЯ ПИЩЕВАРЕНИЯ,
"ОСТРОВА" ПАТОГЕННОСТИ, ГЕНЫ ПАТОГЕННОСТИ, ПЦР, ПРАЙМЕРЫ File Description: text/html
-
9Academic Journal
Authors: Крамарь, Л., Родионова, Н., Арова, А.
Subject Terms: ОСТРЫЕ КИШЕЧНЫЕ ИНФЕКЦИИ, ДЕТИ, КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ
File Description: text/html
-
10Academic Journal
Source: Сборник научных трудов Северо-Кавказского научно-исследовательского института животноводства.
Subject Terms: КОРМЛЕНИЕ СВИНЕЙ,МОЛОЧНОКИСЛЫЕ БАКТЕРИИ,ПРОПИОНОВОКИСЛЫЕ БАКТЕРИИ,КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ,NUTRITION OF PIGS,LACTOBACILUS,BACTERIA OF PROPIONIC ACID,INTESTINAL MICROBIOCENOSIS, 3. Good health
File Description: text/html
-
11Academic Journal
Authors: N. I. Ursova, Н. И. Урсова
Source: Pediatric pharmacology; Том 10, № 2 (2013); 46-56 ; Педиатрическая фармакология; Том 10, № 2 (2013); 46-56 ; 2500-3089 ; 1727-5776
Subject Terms: мультивидовые препараты, intestinal microbiocenosis, bifidus bacteria, lactobacilli, monostrain, multistrain, multispecies drugs, кишечный микробиоценоз, бифидобактерии, лактобациллы, моноштаммовые, мультиштаммовые
File Description: application/pdf
Relation: https://www.pedpharma.ru/jour/article/view/235/350; https://www.pedpharma.ru/jour/article/view/235/538; Шендеров Б. А. Медицинская микробная экология и функциональное питание. Пробиотики и функциональное питание. М.: Грантъ. 2001; 3: 286.; Szajewska H., Mrukowicz J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo controlled trials. J Pediatr Gastroenterol Nutr. 2001; 33: 17–25.; Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr. 2001; 73: 399–405.; Бондаренко В. М. Фарматека. 2012; 13: 89–99.; Gorbach S. L. Probiotics and gastrointestinal health. Am G Gastroenterol. 2000; 95 (Suppl. 1): 2–4.; Hunter J. O., Madden J. A. А review of the role of the gut microflora in irritable bowel syndrome and the effect of probiotics. Br J Nutr. 2002; 88 (Suppl. 1): 67–72.; Marteau P. R., de Vrese M., Cellier C. J., Schrezenmeir J. Protection from gastrointestinal diseases with use of probiotics. Am J Clin Nutr. 2001; 73 (Suppl. 2): 430–36.; Rolfe R. D. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000; 130 (Suppl. 2S): 396–402.; Mercenier A., Pavan S., Pot B. Probiotics as biotherapeutic agent: present khuwledge and future prospects. Curr Pharm Des. 2003; 9: 175–91.; Guidelines for the evaluation of probiotics in food: Joint FAO/WHO Working Group meeting. London, Ontario, Canada, 30 April — 1 May. 2002.; Shida K., Nanno M. Probiotics and immunology: separating the wheat from the chaff. Trends Immynol. 2008; 29: 565–73.; Chapman T. M., Plosker G. L., Figgitt D. P. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs. 2006; 66 (10): 1371–87.; Rachmilevitz D., Katakura K., Karmeli F. et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effect of probiotics murine experimental colitis. Gastroenterol. 2004; 126 (2): 520–28.; Bergonzelli G. E., Blum S., Brussow H. et al. Probiotics as a treatment strategy for gastrountestinal diseases? Digestion. 2005; 72: 57–68.; Penner R., Fedorak R. N., Madsen K. L. Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol. 2005; 5: 596–603.; Ghadimi D., Folster-Holst R. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology. 2008; 213: 677–92.; Metchnikoff E. The prolongation of life. Optimistic studies. London, United Kingdom: William Heinemann. 1907.; Reid G. Regulatory and clinical aspects of dairy probiotics. FAO/WHO Expert consultation on evalution of health and nutritional properties of powder milk with live lactic acid bacteria. Cordoba, Argentina. 2001. Р. 1–34.; FAO/WHO. The food and agriculture organization of the United Nations and the World Health Organization Joint FAO/WHO expert consultation on evalution of health and nutritional propecties of probiotics in food including powder milk with live lactic acid bacteria. 2001 (10–1).; Timmerman H. M., Koning C. J. M., Mulder L., Rombouts F. M., Beynen A. C. Monostrain, multistrain and multispecies probiotics. A comparison of functionality and efficacy. Int J Food Microbiol. 2004; 96: 219–33.; Salminen S., Isolauri E., Onela T. Gut flora in normal and disordered states. Chemotherapy. 1995; 41 (Suppl. 1): 5–15.; Van der Waaij D. Colonization resistance of the Digestive Tract. Japan. 1999. Р. 76–81.; Постникова Е. А., Пикина А. П., Кафарская Л. И., Ефимов Б. А. Журн. микробиол. 2004; 1: 67–69.; Fons M., Gomez A., Karjalainen T. Mechanisms of colonization and colonization resistance of the digestive tract. Microbial Ecol Health Dis Sup. 2000; 2: 240–6.; Bry L., Falk P. G., Midtvedt T., Gordon J. I. A model of hostmicrobial interactions in an open mammalian ecosystem. Science. 1996; 273 (5280): 1380–3.; Hooper L. V., Xu J., Falk P. G., Midtvedt T., Gordon J. I. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci. USA. 1999; 96 (17): 9833–8.; Mowat A. M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol. 2003; 3 (4): 331–41.; Kelly D., Conway S., Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol. 2005; 26 (6): 326–33.; Mayer L., Shao L. Therapeutic potential of oral tolerance. Nat Rev Immunol. 2004; 4 (6): 407–19.; Hawrylowicz C. M., O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol. 2005; 5 (4): 271–83.; Kapsenberg M. L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003; 3 (12): 984–93.; Holzapfel W. H., Haberer P., Geisen R. et al. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr. 2001; 73: 365–73.; Lee Y. K., Lim C. Y., Teng W. L. et al. Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells ant their competition with enterobacteria. Appl Envir Microbiol. 2000; 66 (9): 3692–97.; O'Sullivan D. J. Screening of intestinal microflora for effective probiotic bacteria. J Ag Food Chem. 2001; 49: 1751–60.; Schell M. A., Karmirantzou M., Snel B. et al. The genome sequence of Bifidobacterium longum reflect its adaptation to the human gastrointestinal tract. Proc Natl Sci. USA. 2002; 99 (22): 14422–27.; Tannock G. W. Molecular assessment of intestinal microflora. Am J Clin Nutr. 2001; 73: 410–14.; Resta-Lenert S., Barrett K. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli. Gut. 2003; 52: 988–997.; Putaala H., Salusjarvi T. Effect of four probiotic strains and Echerichia coli O157: H7 on tight junction integrity and cyclooxygenase expression. Res Microbiol. 2008. Doi:10.1016/ j.resmic.2008.08.002.; Gill H. S. Probiotic to enhance anti-infective defenses in the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2003; 17: 755–73.; Oksaharju A., Kankainen M., Kekkonen R. A. et al. Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cell. World J Gastroenterol. 2011; 17: 750–9.; Alakomi H. L., Skytta E., Saarela M. et al. Lactic acid permebilizes gram-negative bacteria by disrupting the outer membrane. Applied Environ Microbiol. 2000; 66: 2001–5.; Pan X., Chen F., Wu T. et al. The acid, bile tolerance and antimicrobial property of Lactobacillus acidophilus NIT. Food Control. 2008. Doi:10.1016/j.foodcont.2008.08.019.; Salminen S., Salminen E. Lactulose lactic acid bacteria intestinal microecology and mucosal protection. Scand J Gastroenterol. 1997; 222: 45–8.; Lanning D. K., Rhee K. J., Knight K. L. Intestinal bacteria and development of the B-lymphocyte repertoire. Trends Immunol. 2005; 26 (8): 419–25.; Cotter P. D., Hill C., Ross R. P. Developing innate immunity for food. Nat Rev Microbiol. 2005; 3: 777–88.; Strompfova V., Laukova A. In vitro study on bacteriocin production of Enterococci associated with chickens. Anaerobe. 2007; 13: 228–37.; Chavez A. M., Menconi M. J., Hodin R. A. et al. Cytokineinduced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med. 1999; 27: 2246–51.; Sobko T., Reinders C. L., Jansson E. A. et al. Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite. Nitric Oxide. 2005; 13: 163–69.; Lundberg J. O., Weitzberg E., Cole J. A. et al. Nitrate, bacteria and human health. Nat Rev Microbiol. 2004; 2: 593–602.; Lu L., Walker A. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr. 2001; 73: 1124–30.; Lebeer S., Vanderleydes G., De Keersmaecker S. C. Genes and molecules of lactobacillus supporting probiotic action. Microbiol Mol Biol Rev. 2008; 72: 728–64.; Perdigon G., Fuller R., Raya R. Lactis acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol. 2001; 2 (1): 27–42.; Лиходед В. Г., Бондаренко В. М. Антиэндотоксиновый иммунитет в регуляции численности микрофлоры кишечника. М.: Медицина. 2007. 216 с.; Vinderola G., Matar C., Perdigon G. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors. Clin Diagn Lab Immunol. 2005; 12 (9): 1075–84.; Isolauri E., Juntunen M., Rautanen T. et al. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics. 1991; 88: 90–7.; Isolauri E., Salminen S., Ouwehand A. C. Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol. 2004; 18: 299–313.; Isolauri E., Kirjavainen P. V., Salminen S. Probiotics: role in the treatment of intestinal infection and inflammation. Gut. 2002; 50 (3): 154–59.; Walker W. A., Goulet O., Morelli L. et al. Progress in the science of probiotics: from cellular microbiology and applied immunology to clinical nutrition. Eur J Nutr. 2006; 45: 1–18.; Бондаренко В. М. Фарматека. 2010; 2: 26–32.; Allen S. J., Okoko B., Martinez E., Gregorio G., Dans L. F. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev. 2004; 2: CD003048.; Lee M. C., Lin L. H., Hung K. L., Wu H. Y. Oral bacterial therapy promotes recovery from acute diarrhea in children. Acta Paediatr. Taiwan. 2001; 42: 301–5.; Sazawal S., Hiremath G., Dhingra U. et al. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006; 6: 474–82.; Hickson M., D'Souza A. L., Muthu N. et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007; 335 (7610): 80.; Nista E. C., Candelli M., Cremonini F. et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther. 2004; 20: 1181–8.; Beausoleil M., Fortier N., Guenette S. et al. Effect of a fermented milk combining Lactobacillus acidophilus C11285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol. 2007; 21: 732–6.; Plummer S., Weaver M. A., Harris J. C. et al. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of Clostridium difficile diarrhea. Int Microbiol. 2004; 7: 59–62.; Tong J. L., Ran Z. H., Shen J. et al. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2007; 25: 155–68.; Sykora J., Valeckova K., Amlerova J. et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication Helicobacter pylori in children:prospective randomized double-blind study. J Clin Gastroenterol. 2005; 39: 692–8.; O'Mahony L., McCarthy J., Kelly P. et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005; 128: 541–51.; Gawronska A., Dziechciarz P., Horvath A., Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther. 2007; 25: 177–84.; https://www.pedpharma.ru/jour/article/view/235
-
12Academic Journal
Authors: Авалуева, Е., Ткаченко, Е., Сказываева, Е., Иванов, С., Оришак, Е., Лапинский, И.
Subject Terms: НЕАЛКОГОЛЬНАЯ ЖИРОВАЯ БОЛЕЗНЬ ПЕЧЕНИ, МЕТАБОЛИЧЕСКИЙ СИНДРОМ, УРСОДЕОКСИХОЛЕВАЯ КИСЛОТА, ТЕРАПИЯ, КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ, МИКРОБНЫЕ МЕТАБОЛИТЫ
File Description: text/html
-
13Academic Journal
Authors: Урсова, Наталия
Subject Terms: ПРОБИОТИКИ, КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ, БИФИДОБАКТЕРИИ, ЛАКТОБАЦИЛЛЫ, МОНОШТАММОВЫЕ, МУЛЬТИШТАММОВЫЕ, МУЛЬТИВИДОВЫЕ ПРЕПАРАТЫ
File Description: text/html
-
14Academic Journal
Authors: Крамарь, О., Калашникова, С.
Subject Terms: МИКРОЭКОЛОГИЯ, КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ, НОРМОЦЕНОЗ, ЭКОЛОГО-ГЕОГРАФИЧЕСКИЕ ФАКТОРЫ, ДИСБАКТЕРИОЗ, МИКРОФЛОРА, МИКРОБИОЛОГИЧЕСКОЕ НЕБЛАГОПОЛУЧИЕ
File Description: text/html
-
15Academic Journal
-
16Academic Journal
Authors: Забашта, Николай, Москаленко, Елена, Кузнецова, Тамара, Глазов, Алексей, Скобликов, Николай, Головко, Елена, Полежаева, Оксана
Subject Terms: СВИНЬИ, КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ, ПРОБИОТИКИ, МОЛОЧНОКИСЛЫЕ БАКТЕРИИ, ИММУНИТЕТ, КАЧЕСТВО И БЕЗОПАСНОСТЬ МЯСОСЫРЬЯ
File Description: text/html
-
17Academic Journal
Subject Terms: СВИНЬИ, КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ, E. COLI, ВОЗРАСТНАЯ ДИНАМИКА
File Description: text/html
-
18Academic Journal
Authors: Волк, С.
Subject Terms: ЯЗВЕННАЯ БОЛЕЗНЬ, ТОЛСТАЯ КИШКА, КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ, ДИСБИОЗ ТОЛСТОЙ КИШКИ
File Description: text/html
-
19Academic Journal
Authors: Джиоев, Юрий, Попкова, Софья, Немченко, Ульяна, Ракова, Елена, Шабанова, Наталья, Иванова, Елена, Юринова, Галина
Subject Terms: БИФИДОБАКТЕРИИ, АССОЦИАЦИЯ ВИДОВ, ПОЛИМЕРАЗНАЯ ЦЕПНАЯ РЕАКЦИЯ, КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ
File Description: text/html
-
20Academic Journal
Authors: Вялкова, А., Гриценко, В., Гордиенко, Л.
Subject Terms: ДЕТИ, ПИЕЛОНЕФРИТ, БАКТЕРИУРИЯ, ЭТИОЛОГИЯ, ВОЗБУДИТЕЛИ, ПАТОГЕНЕЗ, ТЕРАПИЯ, ПРОФИЛАКТИКА, КИШЕЧНЫЙ МИКРОБИОЦЕНОЗ, ДИСБАКТЕРИОЗ КИШЕЧНИКА, КОРРЕКЦИЯ
File Description: text/html
